News

UBS Raises SSE's Rating on Growth Prospects and Solid Foundations

UBS Raises SSE's Rating on Growth Prospects and Solid Foundations

UBS Upgrades SSE to 'Buy' Rating

Analysts at UBS Global Research have recently upgraded the stock rating of SSE plc to "buy" from "neutral." This decision reflects improving fundamentals and the potential growth within its transmission business, indicating positive changes ahead for the company.

Key Factors Driving the Upgrade

Several key factors contributed to this upgrade, highlighting SSE's relative valuation advantage. The analysts emphasized a shift in SSE's business model towards low-risk investments, which enhances its stability and attractiveness in the market.

Challenges Faced by SSE

Despite the upbeat outlook, SSE has faced its share of challenges. The company’s shares have experienced a decline of approximately 13% in 2024, primarily due to rising interest rates and delays in the Dogger Bank offshore wind project. This decline saw SSE trailing its competitors, such as Iberdrola and Enel, by 28% and 18%, respectively.

Strengthening Fundamentals

Regardless of these setbacks, UBS points out that SSE's fundamentals are showing signs of strength. The company is concentrating on regulated transmission capital expenditure and quasi-regulated Contracts for Difference. This strategy effectively minimizes exposure to riskier operations, positioning SSE for a safer investment.

Price Target Adjustment

Reflecting anticipated improvements, UBS has raised its price target for SSE from 1,935p to 1,970p. This adjustment takes into account expected higher capacity payments in the late 2020s, indicating a positive trajectory for the company's stock price.

Transmission Segment Contributions

Analysts note that most of SSE's capital expenditures are aimed at enhancing its transmission segment. Even with regulatory adjustments and planning constraints, UBS estimates that this segment has the potential to increase the company's earnings per share significantly from fiscal years 2025 to 2031.

Financial Strategy Without Asset Sales

Another plus for SSE is its ability to sustain an annual capital expenditure of about £5 billion. This can be achieved without resorting to selling assets or issuing new equity, providing a sense of financial security to investors.

Berwick Bank Offshore Wind Project

One exciting development is the Berwick Bank offshore wind project. Viewed as key in meeting the UK government's ambitious offshore wind goals, UBS estimates this project could add substantial value to SSE, with a potential increase of 200-300p per share upon planning approval.

Impact of Dogger Bank Delays

UBS has also downplayed the financial implications of delays in the Dogger Bank project, insisting that the overall contribution to SSE's earnings remains effective, despite the setbacks encountered.

Potential of Thermal Generation Assets

SSE's thermal generation assets are identified as a potential upside. While these assets are currently not performing at their peak, they may rebound thanks to tighter capacity markets and expected improvements in spark spreads.

Positioning for Clean Energy Transition

This resurgence in thermal assets, combined with SSE's expanding renewable portfolio, positions the company favorably to tap into the transition towards clean energy, appealing to environmentally conscious investors.

Valuation Comparison

From a valuation standpoint, SSE is trading at an enterprise value-to-EBITDA multiple of 9.2x for FY2026E, which is relatively attractive compared to peers like National Grid, trading at 10.8x. This suggests SSE offers a compelling investment opportunity.

Dividend Yield and Growth Prospects

Though SSE has a modest dividend yield of 3.2%, UBS believes the combination of growth potential and a strong balance sheet presents a strong case for investment, making SSE a favorable option in the energy sector.

Frequently Asked Questions

What prompted UBS to upgrade SSE's rating?

UBS upgraded SSE's rating due to improving fundamentals and expected growth in its transmission business.

What challenges has SSE faced recently?

SSE has faced challenges like rising interest rates and delays in the Dogger Bank offshore wind project, leading to a decline in stock performance.

How much has UBS raised its price target for SSE?

UBS has raised its price target for SSE from 1,935p to 1,970p, reflecting positive outlooks for capacity payments.

What are the potential benefits of the Berwick Bank project?

The Berwick Bank offshore wind project could significantly add value to SSE, with estimates of increases of 200-300p per share pending approval.

How does SSE's current valuation compare with its peers?

SSE is valued at an enterprise value-to-EBITDA multiple of 9.2x for FY2026E, which is lower than peers like National Grid at 10.8x, suggesting stronger investment appeal.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Uber Data Breach: Class Action Investigation Begins

Updated Category News Views 74

When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...

Continue Reading
AppLovin Legal Woes: A Deep Dive into Investor Claims

Updated Category News Views 186

AppLovin Faces Legal Heat and Market Scrutiny Bitter truth has a way of crashing like a wave, and AppLovin (NASDAQ: APP) is feeling the brunt of it. Now knee-deep in a securities class action, the firm’s been accused of selling fairy tales about its AI capabilities, leaving investors clutching at substantial losses. If you’ve been banking on their promises between...

Continue Reading
Servier's Data on Tovorafenib Shows Promise in pLGG

Updated Category News Views 193

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...

Continue Reading
Advanta's Game-Changer: Acquiring Misr Hytech to Expand in Africa

Updated Category News Views 218

Advanta's Strategic Move into Africa Alright, let's cut to the chase. Advanta is making a big splash with its acquisition of Misr Hytech, a move that's going to shake things up in Africa's agricultural sector. This isn't just another merger to gloss over with your morning coffee. We're talking about a deal that's supposed to wrap up by January 31, 2027, bringing together...

Continue Reading
CARsgen's CAR-T Breakthrough on China's Insurance List

Updated Category News Views 166

A Game Changer for CAR-T Therapies There's a breeze of optimism blowing from Shanghai these days—a rare sensation in this market of endless skirmishes. CARsgen Therapeutics Holdings Limited, a company entrenched in the development of cutting-edge CAR T-cell therapies, just notched a victory. They've announced that their CAR T-cell therapy product, satricabtagene...

Continue Reading
Novo's CagriSema Trial Shows Promising Obesity Results

Updated Category News Views 255

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Continue Reading
BETR's Slide: Investors Face Big Losses, Leadership Shift

Updated Category News Views 129

BETR Investors Left in the Lurch It's a real trainwreck, folks. Better Home & Finance Holding Company, trading under NASDAQ:BETR, is in the spotlight for all the wrong reasons. The company expanded the class period for its investor lawsuit to include even more dates between March and August 2026, reflecting a torturous ride for shareholders. Their stock cratered by a...

Continue Reading
HiTHIUM Joins Cambridge to Boost Global Energy Storage

Updated Category News Views 372

HiTHIUM and Cambridge's New Energy Venture There's a big splash coming out of Xiamen, folks. HiTHIUM, a heavyweight in the energy storage sector, has decided to team up with the University of Cambridge. They inked a deal aiming to bridge the academic ivory tower with industrial grit, focusing on long-duration energy storage. It was all sealed during the Global Energy...

Continue Reading
LaserAway Expands to 244 Clinics Over 20 Years

Updated Category News Views 203

A Milestone in Aesthetic Dermatology Twenty years, folks. That's a long haul for most businesses, let alone one in the fickle field of aesthetic dermatology. LaserAway, the juggernaut in this arena, has just opened its 244th clinic at 6300 Kingery Hwy in Willowbrook, IL. Nothing to be sneezed at. Imagine running a business, let alone one that's been amping up aesthetic...

Continue Reading
EZaccessMD Data Breach: Class Action Lawsuit Looms

Updated Category News Views 115

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

Continue Reading

Top 5 Most Recently Viewed Articles

AngioDynamics' NanoKnife® System Receives FDA Clearance

Updated Category News Views 191

Introduction to AngioDynamics' Innovation AngioDynamics, Inc. (NASDAQ: ANGO), a forward-thinking medical technology firm, has made significant strides in restoring healthy blood flow and enhancing cancer treatment options. Recently, the company announced its accomplishment in receiving FDA 510(k) clearance for its advanced NanoKnife System, specifically designed for...

Continue Reading
Analyst Predicts iPhone Dominance in Apple's Future Revenues

Updated Category News Views 197

Apple's Revenue Outlook and iPhone Influence A recent analysis by Needham paints a promising picture for Apple Inc (NASDAQ: AAPL) as the company prepares for fiscal year 2025. Analyst Laura Martin affirmed a buy rating for Apple, setting an impressive price target of $260. This forecast is based on a well-crafted Discounted Cash Flow (DCF) model, which includes a cash tax...

Continue Reading
Sitetracker's Record Growth and Vision for Future Success

Updated Category News Views 398

Remarkable Achievements in 2024 for Sitetracker Sitetracker has reached significant milestones marking the close of its fiscal year with outstanding growth and exciting plans for the upcoming year. As a leader in the field of asset lifecycle management, they have positioned themselves strongly in markets worldwide, focusing on providing tools for various critical...

Continue Reading
Olympus Showcases Innovative ENT Solutions at Major Meetings

Updated Category News Views 176

Olympus Highlights Cutting-Edge ENT Solutions Olympus Corporation of the Americas, a leading medical technology company committed to enhancing health and safety, will unveil its extensive ENT portfolio at upcoming annual physician meetings. Attendees will have the opportunity to see how Olympus integrates hybrid endoscopy with advanced imaging and content management...

Continue Reading
Exciting Launch of Tech Mahindra Chess League Season 3

Updated Category News Views 101

Tech Mahindra Global Chess League Season 3 Launches with Excitement The Global Chess League (GCL) has officially begun its Season 3, and excitement fills the air as six teams are set to compete in 34 matches for the coveted championship trophy. The league kicked off at Mumbai's Royal Opera House, a perfect venue for this grand event. Spectacular Opening Ceremony in Mumbai...

Continue Reading